Quick Answer
Jaguar Health, Inc. reported Diluted EPS of $130.69 per share (loss) for fiscal year 2024.
Jaguar Health, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2024 | -$130.69 | +95.1% |
| 2023 | -$2678.17 | -7302.3% |
| 2022 | -$36.18 | +59.0% |
| 2021 | -$88.22 | -2840.7% |
| 2020 | -$3.00 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$6.28 | +76.1% | +38.8% |
| June 30, 2025 | -$10.26 | -285.7% | +38.6% |
| March 31, 2025 | -$16.70 | +80.8% | +36.5% |
| September 30, 2024 | -$26.29 | -16.8% | -888.3% |
| June 30, 2024 | -$2.66 | +93.6% | +96.9% |
| March 31, 2024 | -$87.12 | -3545.2% | -287.2% |
| September 30, 2023 | -$22.50 | -154.8% | +45.6% |
| June 30, 2023 | -$41.35 | -371.5% | -1630.1% |
- Jaguar Health, Inc. showed an increase of +95.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2020–2024 period, Jaguar Health, Inc.’s diluted eps has declined by 4256.3% (from $3.00 per share (loss) to $130.69 per share (loss)).
- The most recent figure is from Jaguar Health, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: